Search results
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 7 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
AstraZeneca (AZN) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 2 years agoAstraZeneca’s AZN first-quarter 2022 core earnings of 95 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 12 months agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
Zacks via Yahoo Finance· 6 months agoAstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN stock has risen 5.1% in the past year compared with an increase of 2% for the...
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 6 months agoHigher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso, Imfinzi and Farxiga, are...
Will AstraZeneca (AZN) Deliver a Beat This Earnings Season?
Zacks via Yahoo Finance· 2 years agoStrong demand trends for AstraZeneca's (AZN) key drugs, Lynparza, Tagrisso, Imfinzi and Farxiga are...
AstraZeneca (AZN) Q4 Earnings & Sales Miss Estimates, Stock Down
Zacks via Yahoo Finance· 3 months agoAstraZeneca (AZN) marginally misses fourth-quarter estimates for earnings and sales. It expects...
2 Top Biotech Stocks to Buy Right Now
Motley Fool· 1 year agoFor today, let's highlight two high-quality pharmaceutical stocks that investors may want to consider buying and holding for the long run. With over...
